Literature DB >> 33405099

Immunoproteasome Inhibitor ONX-0914 Affects Long-Term Potentiation in Murine Hippocampus.

Alexander Maltsev1, Sergei Funikov2, Alexander Burov2, Daria Spasskaya2, Vasilina Ignatyuk3, Tatjana Astakhova3, Yulia Lyupina3, Alexey Deikin4, Vera Tutyaeva2, Natalia Bal1, Vadim Karpov2, Alexey Morozov5.   

Abstract

Entities:  

Keywords:  Immunoproteasome; ONX-0914; Proteasome; Proteasome inhibitor; Synaptic plasticity

Year:  2021        PMID： 33405099     DOI： 10.1007/s11481-020-09973-0

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN： 1557-1890            Impact factor:   4.147


× No keyword cloud information.
  12 in total

1.  A balance of protein synthesis and proteasome-dependent degradation determines the maintenance of LTP.

Authors:  Rosalina Fonseca; Ramunas M Vabulas; F Ulrich Hartl; Tobias Bonhoeffer; U Valentin Nägerl
Journal:  Neuron       Date:  2006-10-19       Impact factor: 17.173

Review 2.  NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms.

Authors:  R C Malenka; R A Nicoll
Journal:  Trends Neurosci       Date:  1993-12       Impact factor: 13.837

3.  LTP suppression by protein synthesis inhibitors is NO-dependent.

Authors:  Alexander V Maltsev; Natalia V Bal; Pavel M Balaban
Journal:  Neuropharmacology       Date:  2018-12-09       Impact factor: 5.250

4.  Interplay between recombinant Hsp70 and proteasomes: proteasome activity modulation and ubiquitin-independent cleavage of Hsp70.

Authors:  Alexey V Morozov; Tatiana M Astakhova; David G Garbuz; George S Krasnov; Natalia V Bobkova; Olga G Zatsepina; Vadim L Karpov; Michail B Evgen'ev
Journal:  Cell Stress Chaperones       Date:  2017-04-26       Impact factor: 3.667

5.  Neuronal induction of the immunoproteasome in Huntington's disease.

Authors:  Miguel Díaz-Hernández; Félix Hernández; Ester Martín-Aparicio; Pilar Gómez-Ramos; María A Morán; José G Castaño; Isidro Ferrer; Jesús Avila; José J Lucas
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

6.  Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes.

Authors:  Gerjan de Bruin; Eva M Huber; Bo-Tao Xin; Eva J van Rooden; Karol Al-Ayed; Kyung-Bo Kim; Alexei F Kisselev; Christoph Driessen; Mario van der Stelt; Gijsbert A van der Marel; Michael Groll; Herman S Overkleeft
Journal:  J Med Chem       Date:  2014-07-15       Impact factor: 7.446

7.  LMP2 Inhibitors as a Potential Treatment for Alzheimer's Disease.

Authors:  Deepak Bhattarai; Min Jae Lee; Ahruem Baek; In Jun Yeo; Zachary Miller; Yu Mi Baek; Sukyeong Lee; Dong-Eun Kim; Jin Tae Hong; Kyung Bo Kim
Journal:  J Med Chem       Date:  2020-03-30       Impact factor: 7.446

8.  Age-related increase in the immunoproteasome content in rat hippocampus: molecular and functional aspects.

Authors:  M Paz Gavilán; Angélica Castaño; Manuel Torres; Manuel Portavella; Cristina Caballero; Sebastián Jiménez; Ana García-Martínez; Juan Parrado; Javier Vitorica; Diego Ruano
Journal:  J Neurochem       Date:  2008-11-19       Impact factor: 5.372

9.  A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis.

Authors:  Tony Muchamuel; Michael Basler; Monette A Aujay; Erika Suzuki; Khalid W Kalim; Christoph Lauer; Catherine Sylvain; Eileen R Ring; Jamie Shields; Jing Jiang; Peter Shwonek; Francesco Parlati; Susan D Demo; Mark K Bennett; Christopher J Kirk; Marcus Groettrup
Journal:  Nat Med       Date:  2009-06-14       Impact factor: 53.440

Review 10.  Biological consequences of structural and functional proteasome diversity.

Authors:  Alexey V Morozov; Vadim L Karpov
Journal:  Heliyon       Date:  2018-11-02
View more
  4 in total

1.  A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes.

Authors:  Alexander Burov; Sergei Funikov; Elmira Vagapova; Alexandra Dalina; Alexander Rezvykh; Elena Shyrokova; Timofey Lebedev; Ekaterina Grigorieva; Vladimir Popenko; Olga Leonova; Daria Spasskaya; Pavel Spirin; Vladimir Prassolov; Vadim Karpov; Alexey Morozov
Journal:  Cells       Date:  2021-11-05       Impact factor: 6.600

2.  Amyloid Aβ25-35 Aggregates Say 'NO' to Long-Term Potentiation in the Hippocampus through Activation of Stress-Induced Phosphatase 1 and Mitochondrial Na+/Ca2+ Exchanger.

Authors:  Alexander V Maltsev; Anna B Nikiforova; Natalia V Bal; Pavel M Balaban
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

3.  Serine/Threonine Phosphatases in LTP: Two B or Not to Be the Protein Synthesis Blocker-Induced Impairment of Early Phase.

Authors:  Alexander V Maltsev; Natalia V Bal; Pavel M Balaban
Journal:  Int J Mol Sci       Date:  2021-05-04       Impact factor: 5.923

Review 4.  Site-Specific Proteasome Inhibitors.

Authors:  Alexei F Kisselev
Journal:  Biomolecules       Date:  2021-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.